Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial [Phase 3]

View source ↗

Summary

This clinical trial update covers the long-term safety and efficacy of SerpinPC in people with Hemophilia A or Hemophilia B who completed prior SerpinPC trials,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SerpinPC

Snippet

Sponsor: ApcinteX Ltd | Conditions: Hemophilia a, Hemophilia B | Phase 3 | Status: TERMINATED